ABUS vs CHRW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ABUS

72.9
AI Score
VS
ABUS Wins

CHRW

66.5
AI Score

Investment Advisor Scores

ABUS

73score
Recommendation
HOLD

CHRW

67score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABUS CHRW Winner
Forward P/E 10.2459 21.5054 ABUS
PEG Ratio 0 1.8224 Tie
Revenue Growth -90.6% 19.3% CHRW
Earnings Growth 0.0% 23.8% CHRW
Tradestie Score 72.9/100 66.5/100 ABUS
Profit Margin 84.2% 3.7% ABUS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ABUS 1M: -11.9% · 3M: -2.4% CHRW 1M: -4.9% · 3M: -23.7%

Current Technical Phase

ABUS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $4.28

CHRW

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.2%) with fading momentum, RSI 47

RSI (14): 46.8 · Price: $142.33

Fundamentals Snapshot

Metric ABUS CHRW
Market Cap — —
Forward P/E -37.7 18.8
Trailing P/E 5.5 26.8
Revenue (TTM) — —
Revenue Growth -0.9% 0.2%
Gross Margin 0.9% 0.1%
Operating Margin -5.7% 0.1%
EPS 0.79 5.24
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, ABUS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.